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Natural products play pivotal roles in drug discovery.
Approximately two thirds of all small-molecule drugs approved
during 1981–2010 have their origins in natural products.1 In theprocess of drug discovery, organic synthesis provides the most
transformative power that can build natural or designed molecules
of interest. The art and science of organic synthesis have evolved
tremendously since its inception.2 ‘Can we synthesize the
molecule?’ is no longer the question. Nowadays, armed with the
strategies and methodologies developed over the past decades,
synthetic chemists have been endowed with the capability to
2134 B.-F. Sun / Tetrahedron Letters 56 (2015) 2133–2140conquer almost any known natural product if given sufﬁcient
resources, efforts, and time. The ideal synthesis is gaining increas-
ing attention from synthetic chemists to confront the demand from
interdisciplinary scientiﬁc community as well as industry to pro-
duce sufﬁcient amount of desired compounds in sustainable ways.3
Organocatalysis has emerged as the third pillar of modern
asymmetric catalysis, along with metal catalysis and biocatalysis.4
Organocatalytic reactions usually feature mild reaction conditions,
adequate functional group tolerance, insensitivity toward air and
moisture, as well as their diverse catalytic mechanisms.5 The
metal-free nature of organocatalytic reactions meets the demands
of green chemistry. The ability of organocatalysis to effect cascade
reactions and one-pot tandem transformations is of particular
importance and has attracted signiﬁcant attention from the chemi-
cal synthesis community. To combine organocatalysis with metal
catalysis is a highly dynamic arena. These efforts have culminated
in a number of elegant total syntheses of natural products with
biological signiﬁcance. A number of elegant reviews have appeared
highlighting respective topics in this research area.6 This Digest
focuses on selected recent examples of total synthesis of natural
and pharmaceutical products enabled by organocatalytic reactions.
These examples are grouped in terms of the mechanisms of the
organocatalytic reactions applied in the total syntheses, including
general base catalysis,5a enamine catalysis,5b iminium catalysis,5c
and Brønsted acid catalysis.5d
Total syntheses enabled by general base catalysis
Dixon’s synthesis of nakadomarin A7
Construction of an all-carbon quaternary center usually consti-
tutes a signiﬁcant challenge in total synthesis, especially when the
quaternary stereogenic carbon is surrounded by ring systems. This
is the case in the total synthesis of nakadomarin A (1).
Nakadomarin A was isolated by Kobayashi and co-workers in
1997 from a sponge collected off the coast of the Kerama Islands,
Okinawa, and exhibits signiﬁcant bioactivities. This moleculeN
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Scheme 2. Fan’s syntheses of lycoramine (8contains a synthetically challenging 8/5/5/5/15/6 hexacyclic ring
system containing a quaternary carbon. Prior to Dixon’s synthesis,
the average step count of the three total syntheses of nakadomarin
A reached 34. In 2009, Dixon’s total synthesis reshaped the land-
scape. Pivoting on an organocatalytic diastereoselective Michael
addition reaction, Dixon and co-workers amazingly telescoped
the total synthesis of nakadomarin A into less than ﬁfteen steps
(longest linear sequence) (Scheme 1). The Michael reaction
between 2 and 3 under the action of 15 mol % of 4 delivered a
91/9 diastereomeric mixture favoring the desired 5 in 57% yield.
When LHMDS or KHMDS was employed in the place of the catalyst
4 to promote this reaction, a diastereoselectivity of 1.5/1 was
observed. Notably, the conﬁguration of the nascent quaternary
carbon was dictated by the strong facial bias of the enolate of the
5/8 bicyclic framework. It was through the hydrogen bonding
interactions between the thiourea catalyst 4 and the nitroalkene
3 that the stereochemistry of the newly generated tertiary carbon
was effectively controlled. The subsequent nitro-Mannich/
lactamization cascade formed the piperidone ring of 6. Selective
reductions transformed 6 to aminol which underwent furan/
iminium cyclization to pentacyclic 7. The camphorsulfonic acid-
assisted Z-selective RCM reaction annulated the 16-membered
macrocycle and ﬁnalized the total synthesis. This synthesis formed
the basis of Dixon’s second generation route for nakadomarin
A, where the geometric selectivity issue in the formation of the
macrocycle was addressed by virtue of alkyne metathesis.8
Fan’s synthesis of lycoramine, galanthamine, and lunarine9
Lycoramine (8), galanthamine (9) and lunarine (10) are
hydrodibenzofuran alkaloids with biological signiﬁcance. In par-
ticular, galanthamine possesses acetylcholinesterase inhibitive
activity, and is clinically used for the treatment of mild to moder-
ate Alzheimer’s disease and various other memory impairments. In
2011, Fan and co-workers reported the collective total synthesis of
these three molecules (Scheme 2). The stereochemistry-deﬁning
step is the asymmetric Michael addition reaction of 11 and 12HN
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nearly quantitative yield of 14 with good enantioselectivity which
could be further enhanced to 99% ee after one recrystallization.
Compound 14was converted to 15 by intramolecular condensation
and conjugate addition. The nitrile was reduced to aldehyde and
condensed with nitromethane to give 16. By a sequence involving
reduction, N-protection and Pictet–Spengler cyclization, nitroalk-
ene 16 was elaborated into the tetracyclic intermediate 17, which
could be readily advanced into lycoramine (8) and galanthamine
(9), respectively, via conventional transformations. In the synthesis
of lunarine (10), 11b and 12 was converted to 19 via a similar
sequence as for the synthesis of 16, except that the catalyst 18
was employed in the starting Michael addition reaction and HWE
oleﬁnation was used to generate the unsaturated ester. A Heck
coupling reaction between 19 and acrylamide gave 20, from which
lunarine (10) was readily generated.
Zhu’s synthesis of trigonoliimine A10
Cinchona-alkaloid-based catalysts represent a group of privi-
leged organocatalysts for promoting conjugate addition reactions,
including those generating quaternary carbons. These are powerful
bifunctional catalysts; usually the quinuclidine moiety in the cata-
lyst activates the nucleophile, while the functional group OH or
thiourea at C60 or C9 activates the electrophile, both via hydrogen
bonding interactions. Recently, Zhu and co-workers developed a
cinchona alkaloid-catalyzed Michael addition reaction. In this reac-
tion, various a-aryl-a-isocyanoacetates add to vinyl phenylse-
lenone under the action of 60-OH cinchona alkaloids, providing
synthetically useful isocyano-bonding quaternary carbons in good
yields and enantioselectivity. By virtue of this new methodology,
they nicely demonstrated the total synthesis of trigonoliimine A
(21) (Scheme 3). The Michael addition reaction of 22 and 23 cat-
alyzed by 24 delivered 25 in 62% yield and 87% ee. This compound
was converted to 27 by a sequence involving nucleophilic displace-
ment of the phenylselenone by sodium azide, acidic hydrolysis of
the isocyano group, and reductive amination of the resultant amine
with aldehyde 26. The azide and the nitro groups in 27 were
successively reduced before being transformed to the aza-spiro
compound 28, which was eventually exposed to POCl3 to effect
the Bischler–Napieralski reaction to furnish trigonoliimine A (21).
Total syntheses powered by enamine catalysis
Hayashi’s and Ma’s syntheses of oseltamivir11,12
Inﬂuenza strikes the world in seasonal epidemics, leading to
hundreds of thousands of annual deaths. The inﬂuenza virusesO CHO
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Scheme 4. Hayashi’s synthehave glycoproteins on their surfaces that bind to sialic acids found
on the surface of human erythrocytes and on the cell membranes
of the upper respiratory tract. Widely used anti-inﬂuenza drugs
are sialic acid analogs that inhibit the viral enzyme neuraminidase,
thereby interfering with the proliferation of viruses. Oseltamivir
(29) is the ﬁrst orally active neuraminidase inhibitor commercially
developed for the ﬁght against both inﬂuenza A and inﬂuenza B
viruses. Efﬁcient synthesis of this molecule containing three
contiguous stereocenters in short steps with a good overall
yield is highly desirable, and challenging. In 2009, Hayashi and
co-workers achieved this goal by realizing the synthesis of
oseltamivir in three one-pot operations with an amazingly high
overall yield (Scheme 4).11 This efﬁcient synthesis relied heavily
on the Michael addition reaction of 30 and 31 catalyzed by
5 mol % of 32-ClCH2COOH via an enamine mechanism, which
generated the multi-functional 33 in quantitative yield with 96%
ee. The subsequent domino reaction of 33 with vinylphosphonate
34 delivered cyclohexenecarboxylate 35 with an undesired
conﬁguration at C5. p-Toluenethiol was then employed to give
the conjugate addition product 36 with the C5 conﬁguration
rectiﬁed. These three steps were integrated into the one-pot
operation which supplied 36 in 70% overall yield. After another
two well executed one-pot operations, the total synthesis of osel-
tamivir was eventually accomplished with 57% overall yield from
nitrooleﬁn 31.
In 2010, Ma and co-workers demonstrated their total synthesis
of oseltamivir based on a similar strategy (Scheme 5).12 Notably,
Ma and co-workers introduced nitroenamides as useful Michael
acceptors. By applying 38 in their total synthesis of oseltamivir,
they signiﬁcantly improved the step economy of the synthetic
route. Their efforts have laid the basis for development of a practi-
cal industrial process for the production of oseltamivir.
Ma’s synthesis of zanamivir, laninamivir, and CS-895813
Recently, Ma’s group reported the total synthesis of three rele-
vant neuraminidase inhibitors, zanamivir (42), laninamivir (43),
and CS-8958 (44) (Scheme 6). This organocatalytic and scalable
synthesis relied on a Michael addition reaction involving nitroe-
namide 45. With 5 mol % of thiourea 46, the Michael addition of
acetone to nitroenamide 45 proceeded smoothly, providing 47 in
72% yield and 98% ee after recrystallization. The subsequent
anti-selective Henry reaction of 47 with 48 was realized with
CuBr2 in the presence of ligand 49. Products 50a and 50bwere then
elaborated into zanamivir (42) and laninamivir (43), respectively,
through the same sequence involving functional group trans-
formations. CS-8958 (44) was obtained by esteriﬁcation of 43.STol
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Organocatalytic intramolecular Michael addition reactions can
be powerful tools for construction of cyclic compounds with two
contiguous stereogenic centers. Thomson and co-workers demon-
strated this strategy in their total synthesis of GB 17 (51)
(Scheme 7). In the presence of 5 mol % ent-32-TFA, 52 underwent
an annulating Michael addition reaction, affording 53 in a nearly
quantitative yield. This highly effective stereocontrol was exerted
by the catalyst, not the substrate, as evidenced by the similar resultobtained with 520. Through the intramolecular Michael addition
reaction of (Z)-oleﬁn 54, compound 53 could be elaborated into
55 and 7-epi-55 as a 1/1 mixture diastereomeric at C7. The geome-
try of the oleﬁn played a critical role in determining the stereo-
chemistry of the addition product; with the (E)-oleﬁn 540 as the
substrate, the Michael addition proceeded with the undesired
sense of stereochemistry at C16 and the C6 stereocenter epimer-
ized under the conditions, leading to formation of 550. 7-epi-55
could be equilibrated upon exposure to base to give a 3/2 mixture
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B.-F. Sun / Tetrahedron Letters 56 (2015) 2133–2140 2137of 55 and 7-epi-55 and recycled. Compound 55was transformed to
56 by conversion of the carbonyl to the oleﬁn and the subsequent
allylation, before being further advanced into GB 17 (51).
Total syntheses powered by iminium catalysis
MacMillan’s synthesis of diazonamide A15
Diazonamides are a structurally unique family of marine natu-
ral products isolated by Fenical and co-workers. Among these,
diazonamide A (57) was identiﬁed to be a potent antimitotic agent,
exhibiting cytotoxicity toward a variety of human cancer cell lines
through interaction with ornithine d-amino-transferase, a
mitochondrial matrix protein. Total synthesis of this molecule
has been intensely explored in the past two decades, with the
original structure being corrected by Harren and co-workers
through synthetic studies. One of the major synthetic challenges
lies in the construction of the C10 quaternary carbon. In 2011,
MacMillan’s group contributed the total synthesis of 57 covering
twenty steps from commercial materials (Scheme 8). Thus, seg-
ments 58 and 59 were assembled via Suzuki coupling and further
converted to 60. Under the action of 61-TCA, the Michael addition
reaction of 60 and propynal went on efﬁciently, providing 62 with
a diastereoselectivity of over 20/1. This reaction established the
C10 quaternary center and the complete benzofuranoindoline core.
Notably, when rac-61 was tested for this reaction, 1/1 dr was
resulted, indicating the formation of the C10 stereocenter was
dominated by the catalyst. Compound 62was subjected to protect-
ing group manipulations, oxidative cleavage, and macrocyclization
by intramolecular aldol reaction, furnishing 63, which was further
advanced into 64 via oxidative aromatization and Ag+ promoted
amidation. Formation of the second oxazole ring followed by
debenzylation and triﬂation generated 65, which was subjected
to a tandem borylation/annulation to yield 66. After initial bromi-
nation of the activated indoline E-ring and hydrolysis of the indolyl
triﬂate, a sequence involving chlorination/debromination/desilyla-
tion was then carried out to furnish diazonamide A (57). This
synthesis elegantly blended organocatalysis and transition-metal
catalysis to attain unprecedented synthetic efﬁciency.
Hong’s synthesis of conicol16
In the past century, total synthesis has been playing an indis-
pensible role in determining the structure of natural products. In
2010, Hong and co-workers accomplished the catalytic enantiose-
lective total synthesis of conicol (67) and settled the stereochemi-
cal issue of this molecule (Scheme 9). Hong’s approach to this
molecule features a domino oxa-Michael–Michael–Michael-aldol
reaction sequence. By employing ent-32-AcOH as the catalyst, the
ﬁrst stage of this one-pot sequence involved the oxa-Michael
addition of 68 and 69 and the ensuing intramolecular Michael
addition, furnishing compound 70. In the second stage, enal 71
was introduced and the Michael-aldol cascade reaction proceeded
to give tricyclic 72. This one-pot sequence delivered 72 in 55%
overall yield with 99% ee. The stereochemistry of this tandem
reaction was established unambiguously through X-ray
crystallographic analysis of relevant products, thus certifying the
stereochemistry of the target molecule. By trimming off theundesired functionalities, compound 72 was transformed to
73, which was further subjected to acylation and deacetoxylation
to give (+)-conicol (67). This asymmetric total synthesis
determined the absolute conﬁguration of (+)-conicol, which had
previously been a mystery due to the lack of an efﬁcient analytical
method.
MacMillan’s synthesis of strychnine, akuammicine, kopsinine,
kopsanone, aspidospermidine, and vincadifformine17
In nature, simple building blocks could be assembled rapidly to
form highly complex and diverse molecular architectures via
enzyme-catalyzed cascade reactions, as exempliﬁed by the biosyn-
thesis of terpenoids. These biological pathways are distinctive from
general chemical synthesis where ‘stop-and-go’ protocols are pre-
vailing with signiﬁcantly lower efﬁciency. Therefore, to mimic nat-
ure’s strategies has been a constant attraction for synthetic
chemists. In 2011, MacMillan and co-workers marked a milestone
in this arena. By realizing an organocatalytic cascade reaction, they
achieved the collective synthesis of six structurally complex ter-
pene indole alkaloids, strychnine (74), akuammicine (75), kopsi-
nine (76), kopsanone (77), aspidospermidine (78) and
vincadifformine (79), each with high step economy (Scheme 10).
In particular, they accomplished the shortest asymmetric synthesis
of strychnine (74), the best-known strychnos alkaloid
(Scheme 10A). This collective total synthesis was centered on a
one-ﬂask, asymmetric Diels–Alder/elimination/conjugate addition
organocascade reaction that coined the key tetracyclic core of the
targets. In this reaction, by forming the corresponding iminium
species with catalyst 81, propynal was activated toward the
Diels–Alder [4+2] cycloaddition with 2-vinyl indole 80, engender-
ing iminium 83. The ensuing elimination and hydrolysis provided
84, which underwent intramolecular conjugate addition to deliver
82 in 82% yield and 97% ee. Employment of the selenide-substi-
tuted 2-vinyl indole, such as 80, as the diene component was
critical for the success. Use of the corresponding methyl-sulﬁde-
substituted 2-vinyl indole as the diene component would lead to
a different product due to the mitigated propensity of the sulﬁde
to undergo elimination. Treatment of 82 with Wilkinson’s catalyst
to effect decarbonylation followed by introduction of a car-
bomethoxy group with COCl2/MeOH and reduction with Dibal-H
resulted in 85 as an inconsequential mixture of oleﬁn isomers.
N-alkylation and ester reduction gave 86 as a proper Heck sub-
strate. The Heck cyclization-lactol formation and the subsequent
debenzylation gave the Wieland–Gumlich aldehyde, which was
converted to strychnine (74) following the know procedure. This
total synthesis delivered strychnine in 12 steps and 6.4% overall
yield from commercially available materials, constituting the
shortest route to enantioenriched strychnine to date. Notably, in
the Heck cyclization, the PMB protecting group was believed criti-
cal in facilitating regioselective b-hydride elimination away from
the indoline ring methine since formation of the N-PMB-substi-
tuted enamine would accompany destabilizing allylic strain. This
destabilizing factor was envisioned in the synthesis of akuam-
micine (75). Thus, compound 85 was subjected to cleavage of the
PMB group with concomitant isomerization of the alkene in
conjugation with the ester group. After installation of the iodoallyl
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2138 B.-F. Sun / Tetrahedron Letters 56 (2015) 2133–2140side chain, the Heck cyclization of 88 was set in motion to produce
akuammicine (75).
The total synthesis of kopsinine (76) and kopsanone (77)
employed a slightly modiﬁed precursor 820 obtained from 800 via
the organocascade reaction (Scheme 10B). Conjugate addition of
the revealed amine to the vinylphosphonium bromide produced
the corresponding ylide that underwent oleﬁnation with the
vicinal aldehyde to furnish 89. Compound 89 was converted via
conventional procedures to 90, and the latter was further subjected
to [4+2] cycloaddition reaction with vinylsulfone to access 91 with
a [2.2.2] bicyclic framework. After desulfurization with Raney
nickel, the total synthesis of kopsinine (76) was accomplished in
14% overall yield spanning 9 steps from commercial materials.
Further, kopsinine was demethylated to give 92, which was
converted to kopsanone (77) simply by heating without solvent.Heck cyclization was also featured in the synthesis of the last
two natural products (Scheme 10C). From ent-820, 94 was obtained
via a sequence involving Wittig reactin, enamine saturation, N-Boc
deprotection and N-allylation. The subsequent Heck cyclization
provided 95, the precursor for both aspidospermidine (78) and
vincadifformine (79). This accomplishment of the collective
syntheses of six complex natural products in 6.4–24% yields with
9–12 steps have highlighted the capability of organocatalysis,
which combined with metal catalysis may provide rapid access
to complex molecular architectures.
Wu’s synthesis of kopsinine and aspidofractine18
Indole alkaloids comprise a rich source of appealing targets that
form a test base for new synthetic methodologies. Recently, Wu
selected kopsinine (76) and aspidofractine (96) as the synthetic
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In this exquisite Michael addition/aza-Michael addition/cyclization
cascade reaction, 97 reacted with propynal under the catalysis of
98 to deliver the key tetracyclic 99 directly, presumably via the
intermediacy of 100 and 101. In the second catalysis by 98, the
conjugate addition of compound 99 to acrolein proceeded to fur-
nish, after reduction, dienamine 102, which underwent the [4+2]
cycloaddition/desulfurization sequence to give 103. After forma-
tion of the last ring by nucleophilic substitution, the total synthesis
of kopsinine (76) was accomplished in a concise manner. The end-
game N-formylation of kopsinine provided aspidofractine (96).
Sun and Lin’s synthesis of englerin A/B, orientalol E/F, and
oxyphyllol19
7,10-Epoxy guaianoids represent a small group of sesquiterpene
natural products. These structurally exquisite natural products
have aroused signiﬁcant attention from the synthesis community
since englerin A and englerin B were disclosed by Beutler and co-
workers to possess potent cytotoxicity toward renal cell carci-
noma. In early 2013, Sun, Lin, and co-workers demonstrated how
an organocatalytic [4+3] cycloaddition reaction could be tamed
for the production of a collection of natural products including
englerin A (104), englerin B (105), orientalol F (106), oxyphyllol
(107), and orientalol E (108) (Scheme 12). The [4+3] cycloaddition
reaction catalyzed by 61-TFA involved the unsymmetrically substi-
tuted furan 109 and dienal 110, affording two regioisomers in a
ratio of 2.4/1 favoring the desirable 111. The TMS group was
deemed to play a critical role in the stereochemical guidance: the
benzyl group and t-butyl group of catalyst 61 occupy the a face
of iminium 113, while the even bulkier TMS group blocks its b face,
forcing 109 to approach from the a face through the endo120
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Compound 111 was subjected to a sequence to give 114, which
was triﬂated before undergoing Heck cyclization to furnish guaiane
triene 115. Selective epoxidation of the trisubstituted oleﬁn
followed by SN20-type hydride delivery provided allylic alcohol
116, which after hydrogenation with Pd/C gave orientalol F (106).
Formal hydration of the disubstituted oleﬁn via the hydrob-
oration/oxidation procedure generated diol 117, which was
readily converted into englerin A (104) and englerin B (105)
by esteriﬁcation and saponiﬁcation. The directed hydrogenation
of 116 with Crabtree’s catalyst resulted in oxyphyllol (107).
Eventually, a three-step sequence involving acylation, chemoselective
and stereospeciﬁc C–H oxidation, and saponiﬁcation produced
orientalol E (108).
Total syntheses featuring Brønsted acid catalysis
Zhu’s synthesis of rhazinilam and leucomidine B20
Desymmetrization represents an effective strategy for generat-
ing chiral all-carbon quaternary centers. The desymmetrization of
prochiral diesters via enzymatic hydrolysis has been a powerful
method. Nevertheless, it is less efﬁcient for long-chain-bridged
diesters, such as dimethyl 118 (Scheme 13), which is the key
precursor in several indole alkaloid syntheses accomplished
by Kuehne. Recently, Zhu and co-workers developed a catalytic
desymmetrization method to access 119 enantioselectively
(Scheme 13). This desymmetrization was realized by the alcoholy-
sis of bicyclic bislactone 120 catalyzed by the chiral Brønsted acid
121. Aldehyde 119 was secured in 95% yield and 84% ee, and was
utilized for the total synthesis of rhazinilam (122) and leucomidineNO2 N+
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2140 B.-F. Sun / Tetrahedron Letters 56 (2015) 2133–2140B (123). Compound 119 was converted to 124 before being elabo-
rated into tetrahydropyridine 125, the common precursor to the
two natural products. The N-allylation of 125 by 126 produced imi-
nium salt 127, which upon heating in toluene in the presence of
Ag2CO3 under an inert atmosphere delivered 128. Reduction of
the nitro group and lactamization engendered rhazinilam (122).
On the other hand, heating the mixture of 125 and 129 resulted
in 130 as a 1/1 diastereomeric mixture, probably via the inter-
mediacy of 131, before further proceeding to leucomidine B (123).
List’s synthesis of estrone21
Steroids have captured the imagination of synthetic chemists
for decades owing to their appealing molecular architecture as well
as their biological signiﬁcance. While the female sex hormone
estrone (132) has been the target of numerous syntheses, the
synthesis developed by Torgov in 1963, albeit racemic, appeared
particularly efﬁcient. Recently, List and co-workers achieved the
asymmetric synthesis of 132 by virtue of a catalytic enantioselec-
tive Torgov cyclization (Scheme 14). The substrate 134 was readily
prepared from 133 via a two-step procedure. Torgov cyclization
entails strong acidic conditions. In List’s work, a highly Brønsted
acidic disulfonimide was selected out as the catalyst. Thus, in the
presence of only 5 mol % of 136 at low temperature for 4 days,
the Torgov cyclization of 134 went on smoothly to deliver 135 in
95% yield and 93% ee. After one recrystallization, 135 could be
isolated in 88% yield with 99.8% ee. The Torgov cyclization of 134
presumably involves these consecutive reactions: (1) isomeriza-
tion of 134–137; (2) Prins reaction of 137 that ends in depro-
tonation furnishing 138 as an oleﬁn mixture; and (3)
dehydration and oleﬁn isomerization. The strong acidic conditions
are necessary that ensure the ﬁnal product as the desired
thermodynamically most stabilized one. Torgov diene was then
hydrogenated to give 139, which furnished estrone (132) after
demethylation.Conclusions and perspectives
Organocatalytic reactions generally involve convenient, mild,
and metal-free conditions, and are amenable to the construction
of molecular architectures with complexity and diversity in
enantioselective manner. These virtues bestow them an edge in
synthesis of natural and pharmaceutical products. Selected con-
tributions summarized in this Digest highlight the importance of
organocatalytic reactions in fostering structures of interest,
particularly quaternary stereogenic carbons and polycyclic sys-
tems embedded in complex molecules with biological signiﬁcance.
We hope this Digest will inspire more efforts in applying
organocatalytic transformations in total synthesis of complex
natural products. On the other hand, organocatalytic reactionsare still underdeveloped, and some of the organocatalytic reactions
are far from being satisfactory. Therefore, further development of
organocatalytic reactions in both breadth and depth is anticipated.
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